# 68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer

> **NCT05160051** · PHASE2 · COMPLETED · sponsor: **University Hospital, Essen** · enrollment: 158 (actual)

## Conditions studied

- Tumor, Solid

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-FAPI-46 PET Scan

## Key facts

- **NCT ID:** NCT05160051
- **Lead sponsor:** University Hospital, Essen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2024-03-06
- **Final completion:** 2024-03-06
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05160051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05160051, "68Ga-FAPI-46 PET for Imaging of FAP Expressing Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05160051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*